SCHEMBL7422734

SCHEMBL7422734

CCCc1[nH]c2cc(C(=O)O)ccc2c1C(=O)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 3/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PPARG P37231 2/20 0.43
PSMD14 O00487 1/20 0.43
RECQL P46063 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PARP1 P09874 3/20 0.41
MEN1 O00255 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
FGFR1 P11362 1/20 0.40
FLT1 P17948 1/20 0.40
KDR P35968 1/20 0.40
DYRK1A Q13627 1/20 0.40
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7424222 0.89 HSD17B10 (0.43) KDM4EKMT2AALDH1A1GAAHSD17B10
SCHEMBL7422800 0.86 KMT2A (0.58) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL27483791 0.85 KDM4E (0.46) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL7416246 0.82 ALOX5 (0.44) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL8556645 0.81 PARP1 (0.52) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL7423806 0.81 KMT2A (0.41) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL7467711 0.81 KDM4E (0.43) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL8555826 0.81 KMT2A (0.44) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL7415654 0.80 KMT2A (0.44) KDM4EKMT2AALDH1A1GAAHPGD
SCHEMBL7461274 0.80 KDM4E (0.42) KDM4EKMT2AALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
CN-1187812-A Indole derivatives as CGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO (JP) 1998-07-15 CN disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed